This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
SOURCE: Trent & Company
“Rediscovering Intimacy” Joint Partnership to Help Women Recover Intimacy after Breast Cancer with Personal Massagers
Stockholm / San Jose (PRWEB) October 08, 2012
Swedish designer brand LELO has partnered with Breastcancer.org, the leading online expert resource for information and support on breast health and breast cancer for Rediscovering Intimacy, an initiative focused on recapturing intimacy for women affected by breast cancer and their partners.
For the month of October, LELO will be donating 50% of the proceeds from sales of its bestselling LILY personal massager through LELO.com to the charity, helping Breastcancer.org continue to support those affected by breast cancer with their extensive and authoritative information.
Long regarded as the standard-bearers of quality and innovation during their 10 years in the intimate lifestyle industry, LELO is the world’s first-ever provider of personal massagers to embark on a significant partnership during Breast Cancer Awareness month. It was seen as an ideal partner for Breastcancer.org due to its premium product portfolio and global presence in as many as 50 international markets. More than this, the attention LELO pays to the safety and quality of their personal massagers, further supported by the recent integration of LELO’s own Medical Advisory Board in 2009, aligns with the Recovering Intimacy campaign for women with a history of breast cancer.
LELO’s Medical Advisory Board of 12 independent medical specialists plays a vital role in lending credence to the fact that optimal sexual health and wellness is vital to a person’s overall health and wellness. Breastcancer.org’s mission of providing those affected by breast cancer with in-depth information about how breast cancer can influence all aspects of their lives includes sexuality and intimacy issues.
Dr. Michael Krychman, LELO Medical Advisory Board member and expert in the field of survivorship medicine, knows that breast cancer and its treatments often leads to a disconnect between a woman’s brain and body; her body often feels different, and in some cases not her own. These views are echoed by Breastcancer.org president and founder Dr. Marisa Weiss, who champions the use of intimate massagers among cancer patients as a way to prolong foreplay and assist sexual functions that can be affected by cancer medications and chemotherapy.
About LELO’s partnership with Breastcancer.org, LELO USA Marketing Director Donna Faro said, “Sensual well-being is one aspect of a woman’s overall health that is often overlooked, and that’s why we’re glad to be joining with Breastcancer.org, whose commitment to women everywhere has been an incredibly positive one. We hope our involvement will significantly benefit the mission of Breastcancer.org to raise awareness and support for this most important cause.”
NOTE TO EDITORS: For more information about Breastcancer.org, email pgreen(at)breastcancer(dot)org.
For more information about LELO, e-mail cecilia.minges(at)lelo(dot)com.
LELO is the world's leading designer brand for intimate lifestyle products. On launching in 2003, LELO transformed the look, feel and function of how personal massagers were perceived, and now applies the same commitment to quality and innovation through luxurious bedroom accessories, massage oils, soy massage candles and a premium line of silk intimate apparel.
LELO is the Swedish company behind LELO, and also holds the Intimina and PicoBong brands under the LELO group, where offices extend from Stockholm to San Jose, from Sydney to Shanghai.
Breastcancer.org is the #1 online resource for breast health and breast cancer information and support, with more than 6,000 pages of expert-reviewed information and a robust, dynamic peer support community. A nonprofit organization, Breastcancer.org receives more than 12 million visits each year.
For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/10/prweb9991551.htm